Answer
Onivyde pegylated liposomal is not recommended for patients with severe renal impairment, defined as creatinine clearance (CLcr) below 30 ml/min.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusionServier Laboratories Limited · emc · SmPC §4.2 Posology and method of administration · Version 13Document updated
Sources checked